alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Research

27,380 Alzheimer's and dementia studies in plain English, each scored out of 100.

Find studies

Showing 176–200 of 202 studies matching “financial” (page 8 of 9) · 27,380 in the whole library · How the 0–100 score works

Browse by subject, author or institution

Each number is how many studies that link shows, with your other filters kept.

Subjects

Authors

Names as each record prints them; the same person can appear under two spellings.

Institutions

From OpenAlex; 12,859 studies have no institution on record and are not counted here.

A note on reading research. One study is rarely the final word.

We try to note the size of a study, whether it was in humans or animals, and how early-stage the finding is. If a summary here doesn't make that clear, treat it with extra caution and check the original source.

Changing the food environment: the effect of trained volunteers on mealtime care for older people in hospital

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Proceedings of The Nutrition Society 2017-10-29

This review will describe the evidence for changing the hospital environment to improve nutrition of older people, with particular emphasis on the role of additional mealtime assistance. 2 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Changes to Medicare Advantage Risk Adjustment and Dementia Diagnosis in Older Adults

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Alzheimer s & Dementia 2024-12-01

Financial incentives to detect dementia resulted in more dementia diagnoses, particularly among persons at high risk of dementia and of undetected dementia but also raises concerns about diagnostic upcoding and the potential for over‐diagnosis. 3 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

[The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]

✓ Peer-reviewed alzhub usefulness score 32 out of 100. Fortschritte der Neurologie-Psychiatrie 2022-07-21

Dementias are expensive diseases: the net annual cost in European healthcare is about € 28.000 per case with a strong stage dependency, of which medical care accounts for about 19%. 2 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

The Inaugural Voyage of the South Asian Journal of Geriatric Medicine, Surgery, Palliative Care, and Hospice

✓ Peer-reviewed alzhub usefulness score 31 out of 100. South Asian Journal of Geriatric Medicine Surgery Palliative Care & Hospice 2026-01-01

This Journal is not only a new publication but also the culmination of a shared vision and a timely response to one of the most significant demographic shifts in human history: the rapid aging of the South Asian population. 5 key findings →

Evidence: high

Full summary, score breakdown and related studies → Original source Free full text

Integrated care organizations: Medicare financing for care at home

✓ Peer-reviewed alzhub usefulness score 30 out of 100. The American journal of managed care 2016-11-01

A targeted HCBS benefit could be added to Medicare and financed with income-related cost sharing ranging from 5% to 50%, a premium paid by Medicare beneficiaries of approximately $42 a month, and payroll taxes estimated at around 0.4% of earnings on employers and employees. 3 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Full text may need a subscription

Impact of a regimen-level prior authorization tool on provider adherence to clinical guidelines’ and cost savings in a Medicare advantage population

✓ Peer-reviewed alzhub usefulness score 29 out of 100. Journal of Clinical Oncology 2021-05-20

From April-December 2020, 279 PAs were submitted via NLX and 83% were automatically approved in real-time. 5 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Full text may need a subscription

HEDIS Measures for Geriatric Care Quality: Evidence, Equity, and a Governance Framework

✓ Peer-reviewed alzhub usefulness score 27 out of 100. Zenodo (CERN European Organization for Nuclear Research) 2023-01-30

The Healthcare Effectiveness Data and Information Set provides the dominant quality measurement framework for Medicare Advantage and commercial health plans, yet HEDIS lacks validated geriatric-specific quality indicators, equitable measurement standards for diverse older adult populations, and governance controls calibrated to the high-stakes Star Ratings financial incentive context. 5 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

NOVEL DRUG DELIVERY SYSTEM: A PANDORA BOX FOR THE MANAGE MENT OF ALZHEIMER NOVEL DRUG DELIVERY IN ALZHEIMER

✓ Peer-reviewed alzhub usefulness score 27 out of 100. Genetics and Molecular Research 2026-06-02

One of the biggest health issues of the twenty-first century is Alzheimer's disease (AD), which is the most prevalent cause of dementia. 1 key finding →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Assembly Votes Challenge Threats to Patient Care

✓ Peer-reviewed alzhub usefulness score 22 out of 100. Psychiatric News 2006-12-01

Back to table of contents Previous article Next article Association NewsFull AccessAssembly Votes Challenge Threats to Patient CareKen HausmanKen HausmanSearch for more papers by this authorPublished Online:1 Dec 2006https://doi.org/10.1176/pn.41.23.0004Patient care issues had a prominent place on the agenda for the APA Assembly's November meeting in Washington, D.C., and several dealt with prescribing concerns in a health care environment that is not always patient friendly. 1 key finding →

Evidence: low

Full summary, score breakdown and related studies → Original source Full text may need a subscription

At Home Versus in a Nursing Home: Long-Term Care Settings and Marginal Utility

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Not indexed 2023

Marginal utility of financial resources when needing long-term care, and the related incentives for precautionary savings and insurance, may vary significantly by whether one receives care at home or in a nursing home. 5 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source

Navigating young-onset dementia caregiving: A qualitative study of unmet needs, support, and resilience

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-07-27

Although caregivers demonstrated resilience and adaptive coping, YOD caregiving in Singapore remained constrained by limited access to visible, tailored, and age-appropriate support. 3 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source

Caring in the Shadows: The Lived Experiences of family Caregivers of Older Adults with Dementia in Fragile and Conflict-Affected Setting in Ethiopia

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-07-20

Caregiving for older adults with dementia in Northern Ethiopia is a totalizing and demanding experience that profoundly affects caregivers’ lives. 2 key findings →

Participants: 25 Evidence: low

Full summary, score breakdown and related studies → Original source

↑ Change the filters

Where “Free full text” comes from

Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled. Show only studies that are free to read

How the 0–100 score works — and why some entries are capped

This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.

  • Journal tier up to 10 pts
  • Journal's citation record up to 4 pts
  • Study design up to 12 pts
  • Strength of evidence up to 5 pts
  • Peer-review validation up to 10 pts
  • How recent up to 5 pts
  • Sample size up to 4 pts
  • Effect reported up to 3 pts
  • Studied in people up to 3 pts
  • Randomised / blinded up to 2 pts
  • Times cited up to 7 pts
  • Citations per year up to 5 pts
  • Impact for its field and year up to 6 pts
  • Cited by studies here up to 6 pts
  • Still being cited up to 4 pts
  • Senior author's track record up to 4 pts
  • Institution's track record up to 3 pts
  • Multi-centre collaboration up to 3 pts
  • Indexed in PubMed up to 2 pts
  • Free to read up to 2 pts

Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.

Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.

We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.

The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.

See the whole rubric drawn out → — four charts covering all 27,380 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.

What this library is — and isn't

This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 27,380 records, built mostly from automated pulls of Europe PMC (60.6% of the library) and OpenAlex (18.6%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.

1,032 records (3.8% of the library) are not peer-reviewed — 962 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.

See the full, machine-readable breakdown of this library's coverage →

Newest studies, as a dated timeline →    Atom feed